Education5 min read
Magnesium Glycinate for Cancer Patients: Benefits, Side Effects & Dosage
Dr. Vrundali Kannoth
+918929672099
Call Us
Understanding Cancer Clinical Trials: A Guide for Patients in India
Dr. Vrundali Kannoth|5 min read|
India recorded 1.4 million new cancer cases in 2023, and that number is climbing. For many patients and families, a diagnosis not only brings fear, but an avalanche of questions: What are my options? Is there something newer? What if the standard treatment isn't enough?
That's often when cancer clinical trials come up. Yet, most people don't fully understand what they are, who can join them, or whether they're worth considering. This guide walks you through everything, so you can get a better idea of how it works.
What are cancer clinical trials?
Cancer clinical trials are structured research studies that test new treatments, drugs, combinations, or procedures in real patients. They are the bridge between a promising laboratory discovery and a treatment that doctors can offer everyone.
Every treatment available today, from chemotherapy to immunotherapy, was once tested in a clinical trial.
India's own Clinical Trials Registry (CTRI) has recorded nearly 2,000 cancer trials between 2007 and 2021, for:
- •Breast cancer (17%)
- •Head and neck cancer (9.8%)
- •Lung cancer (9.6%)
These cancer research clinical trials run under strict ethical and regulatory oversight, overseen by the Drugs Controller General of India (DCGI) and institutional ethics committees.
Cancer clinical trial phases explained
Cancer clinical trial phases build on each other in a structured sequence, each phase answering a different question before the next begins.
And if you've ever wondered - do these actually involve real patients, or just lab tests? The answer is yes, real people, under close medical supervision. Here's how each phase works:
Phase 1 - Is it safe?
- •A small group of patients (typically 20–80) receives the new treatment
- •The goal is to find a safe dosage and understand potential side effects. For instance, chemotherapy side effects or other adverse reactions before the trial scales up
- •Most Phase 1 cancer treatment clinical trials are conducted at large academic centres like AIIMS, Tata Memorial, or the National Cancer Grid institutions
Phase 2 - Does it work?
- •A larger group (up to a few hundred patients) participates
- •Researchers evaluate whether the treatment shows real effectiveness for a specific cancer type
- •Cancer treatment clinical trials at this phase often show whether a drug is worth advancing further
Phase 3 - How does it compare?
- •Hundreds or thousands of patients across multiple sites participate
- •The new treatment is compared against the current standard of care
- •This is where current clinical trials for cancer patients have the most direct impact on future treatment guidelines
Phase 4 - Long-term monitoring
- •Takes place after regulatory approval from the DCGI
- •Tracks long-term safety, rare side effects, and real-world outcomes over time
- •Once Phase 4 data is strong enough, the treatment becomes publicly available through hospitals and pharmacies
- •The full journey from Phase 1 to your oncologist’s prescription can take anywhere from 10 to 15 years
Who is eligible for cancer clinical trials?
This is one of the most common questions patients ask, and one of the most important. Cancer clinical trial eligibility criteria vary by study, but they generally look at:
- Type and stage of cancer: Many trials target specific tumours across all stages of cancer; metastatic cancer clinical trials, for instance, focus specifically on patients with advanced or spread disease
- Previous treatments: Whether you've received chemotherapy, radiation, or surgery often determines eligibility
- Age and overall health: Some clinical trials for cancer patients have age ranges or require certain organ function levels
- Genetic markers: Precision oncology trials may require a specific mutation identified through a biopsy test for cancer
- Location: Access matters too; research has shown significant geographic disparity in India, with urban centres like Mumbai, Delhi, and Chennai hosting the overwhelming majority of trials
If you're unsure whether a trial is available near you, CTRI (ctri.nic.in), India's official clinical trials registry, is the best place to check. You can even simply ask your oncologist, who can point you in the right direction.
How do cancer clinical trials work?
Now, the part most people are actually curious about - what does being in a trial day-to-day look like? Here's how the process works, from your first enquiry to your last check-in:
The enrollment process
After expressing interest, you'll go through a screening phase, which is a review of your medical history, recent scans (like a PET scan for cancer or a CT scan), blood work, and sometimes genetic testing.
If you meet the criteria, you'll be formally enrolled and given a detailed informed consent document to review and sign. Remember, this is your right. Understand what you're agreeing to before committing.
Endpoints in cancer clinical trials
Every trial defines endpoints before it begins. These are the specific outcomes used to determine if the treatment is working. Common ones include:
- Overall survival (OS): How long patients live after treatment, which directly impacts overall cancer survival rates
- Progression-free survival (PFS): Time before the cancer begins growing again
- Tumour response rate: How much the tumour shrinks
- Quality of life scores: How the treatment affects daily functioning
During the trial
- You follow a specific treatment protocol set by the research team
- Regular check-ins, imaging, and lab tests track your progress and safety
- A dedicated team of doctors, nurses, and coordinators supports you at every step
- You can ask questions or step back at any point
When the trial ends
Once your participation wraps up, you don't just disappear from the radar. Most trials include a follow-up period, where your health is monitored for weeks, months, or sometimes years after treatment ends. Since a CT scan can detect cancer recurrence early, it remains a routine part of this phase.
Your data contributes to the final results, and if the treatment worked well for you, your oncologist will discuss next steps for continuing your care.
How successful are clinical trials for cancer?
It depends on the endpoint. A trial might not cure cancer, but it can meaningfully extend life or reduce suffering, and that matters enormously.
Take NexCAR19, developed by IIT Bombay's ImmunoACT and trialled at Tata Memorial Hospital, Mumbai. 67% of patients with advanced lymphoma or leukaemia saw significant cancer reduction, with roughly half achieving complete remission.
It was approved by India's DCGI in 2023 and costs around ₹40 lakh, making it one-tenth the price of the same therapy in the US. That's what cancer clinical trials can make possible.
Benefits and risks of clinical trials for cancer patients
Joining cancer clinical trials isn't a decision to take lightly, but it's also not one to dismiss. Like any treatment path, there are real upsides and honest trade-offs worth understanding before you decide.
Benefits
- Early access to new treatments: Including chemotherapy drugs or other options in clinical trials not yet publicly available
- Innovative approaches: Such as nanobots cancer clinical trials and nanoparticles cancer treatment clinical trials. These use microscopic technology to deliver treatment directly to tumour cells with great precision
- Closer monitoring: Trial participants are typically seen more frequently than those on standard cancer treatment
- Contributing to the bigger picture: Your participation helps future patients across India and beyond
Potential risks
- The experimental treatment may not outperform current options: It may work differently for different patients, and there's always a chance the new therapy shows no significant advantage over what's already available
- In randomised trials, you may be assigned to the standard treatment arm: This is a scientifically controlled process to ensure fair comparison, and not a random oversight
- Side effects may be new or not fully understood yet: As the treatment is still being studied, some reactions may be unexpected or harder to predict than with established therapies
- The time commitment can be significant: More frequent visits, additional tests, and stricter protocols mean clinical trials demand more of your time and energy than standard care
Speak to an oncologist about cancer clinical trials today
Many patients assume trials are only for when nothing else has worked. That's not true. People join cancer clinical trials at every stage, from newly diagnosed to advanced disease, and for many, it opens doors they didn't know existed.
If you're wondering whether a trial could be right for you, the most important step is a direct conversation with an experienced oncologist.
They can review your case, check what trials are currently open, and help you decide, without pressure or rush. Reach out to a trusted oncology centre near you. You deserve to know every option that's available.
FAQs
Yes, absolutely. Participation is always voluntary. You can withdraw at any point, for any reason, and it will not affect your access to other cancer treatment or medical care.
Related Blogs
Education5 min read
Saccharomyces Boulardii in Cancer Care: Benefits, Uses & Side Effects
Dr. Vrundali Kannoth
